Altamira Therapeutics Ltd. Amended Reports
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2024-07-01: Form 20-F/A; Period of report 2023-12-31; Description AMENDMENT NO. 2 TO FORM 20-F; Document ea0208669-20fa2_altamira.htm.
- 2024-04-22: Form 20-F/A; Period of report 2023-12-31; Description AMENDMENT NO. 1 TO FORM 20-F; Document ea0204302-20fa1_altamira.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2024-07-01 | 20-F/A | 2023-12-31 | AMENDMENT NO. 2 TO FORM 20-F | ea0208669-20fa2_altamira.htm |
| 2024-04-22 | 20-F/A | 2023-12-31 | AMENDMENT NO. 1 TO FORM 20-F | ea0204302-20fa1_altamira.htm |